Literature DB >> 18692213

Elucidation of strain-specific interaction of a GII-4 norovirus with HBGA receptors by site-directed mutagenesis study.

Ming Tan1, Ming Xia, Sheng Cao, Pengwei Huang, Tibor Farkas, Jarek Meller, Rashmi S Hegde, Xuemei Li, Zihe Rao, Xi Jiang.   

Abstract

Noroviruses interact with histo-blood group antigen (HBGA) receptors in a strain-specific manner probably detecting subtle structural differences in the carbohydrate receptors. The specific recognition of types A and B antigens by various norovirus strains is a typical example. The only difference between the types A and B antigens is the acetamide linked to the terminal galactose of the A but not to the B antigen. The crystal structure of the P dimer of a GII-4 norovirus (VA387) bound to types A and B trisaccharides has elucidated the A/B binding site on the capsid but did not explain the binding specificity of the two antigens. In this study, using site-directed mutagenesis, we have identified three residues on the VA387 capsid that are sterically close to the acetamide and are required for binding to A but not B antigens, indicating that the acetamide determines the binding specificity between the A and B antigens. Further mutational analysis showed that a nearby open cavity may also be involved in binding specificity to HBGAs. In addition, a systematic mutational analysis of residues in and around the binding interface has identified a group of amino acids that are required for binding but do not have direct contact with the carbohydrate antigens, implying that these residues may be involved in the structural integrity of the receptor binding interface. Taken together, our study provides new insights into the carbohydrate/capsid interactions which are a valuable complement to the atomic structures in understanding the virus/host interaction and in the future design of antiviral agents.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18692213      PMCID: PMC3503251          DOI: 10.1016/j.virol.2008.06.041

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  22 in total

1.  Genotyping of GII.4 and GIIb norovirus RT-PCR amplicons by RFLP analysis.

Authors:  Stefania Ramirez; Giovanni M Giammanco; Simona De Grazia; Claudia Colomba; Vito Martella; Serenella Arista
Journal:  J Virol Methods       Date:  2007-10-22       Impact factor: 2.014

2.  Food-borne viruses in Europe network report: the norovirus GII.4 2006b (for US named Minerva-like, for Japan Kobe034-like, for UK V6) variant now dominant in early seasonal surveillance.

Authors:  J Siebenga; Annelies Kroneman; H Vennema; E Duizer; M Koopmans
Journal:  Euro Surveill       Date:  2008-01-10

3.  Norwalk virus infection and disease is associated with ABO histo-blood group type.

Authors:  Anne M Hutson; Robert L Atmar; David Y Graham; Mary K Estes
Journal:  J Infect Dis       Date:  2002-04-16       Impact factor: 5.226

4.  Structural basis for the receptor binding specificity of Norwalk virus.

Authors:  Weiming Bu; Aygun Mamedova; Ming Tan; Ming Xia; Xi Jiang; Rashmi S Hegde
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

5.  Structural basis for the recognition of blood group trisaccharides by norovirus.

Authors:  Sheng Cao; Zhiyong Lou; Ming Tan; Yutao Chen; Yijin Liu; Zhushan Zhang; Xuejun C Zhang; Xi Jiang; Xuemei Li; Zihe Rao
Journal:  J Virol       Date:  2007-03-28       Impact factor: 5.103

6.  Epidemics of gastroenteritis during 2006 were associated with the spread of norovirus GII.4 variants 2006a and 2006b.

Authors:  Elise T-V Tu; Rowena A Bull; Gail E Greening; Joanne Hewitt; Michael J Lyon; John A Marshall; Christopher J McIver; William D Rawlinson; Peter A White
Journal:  Clin Infect Dis       Date:  2008-02-01       Impact factor: 9.079

7.  Outbreak studies of a GII-3 and a GII-4 norovirus revealed an association between HBGA phenotypes and viral infection.

Authors:  Ming Tan; Miao Jin; Huaping Xie; Zhaojun Duan; Xi Jiang; Zhaoyin Fang
Journal:  J Med Virol       Date:  2008-07       Impact factor: 2.327

Review 8.  Norovirus-host interaction: implications for disease control and prevention.

Authors:  Ming Tan; Xi Jiang
Journal:  Expert Rev Mol Med       Date:  2007-07-11       Impact factor: 5.600

9.  Mechanisms of GII.4 norovirus persistence in human populations.

Authors:  Lisa C Lindesmith; Eric F Donaldson; Anna D Lobue; Jennifer L Cannon; Du-Ping Zheng; Jan Vinje; Ralph S Baric
Journal:  PLoS Med       Date:  2008-02       Impact factor: 11.069

10.  Emergence of new norovirus variants on spring cruise ships and prediction of winter epidemics.

Authors:  Linda Verhoef; Evelyn Depoortere; Ingeborg Boxman; Erwin Duizer; Yvonne van Duynhoven; John Harris; Christina Johnsen; Annelies Kroneman; Soizick Le Guyader; Wilina Lim; Leena Maunula; Hege Meldal; Rod Ratcliff; Gábor Reuter; Eckart Schreier; Joukje Siebenga; Kirsti Vainio; Carmen Varela; Harry Vennema; Marion Koopmans
Journal:  Emerg Infect Dis       Date:  2008-02       Impact factor: 6.883

View more
  50 in total

1.  Norovirus P particle, a novel platform for vaccine development and antibody production.

Authors:  Ming Tan; Pengwei Huang; Ming Xia; Ping-An Fang; Weiming Zhong; Monica McNeal; Chao Wei; Wen Jiang; Xi Jiang
Journal:  J Virol       Date:  2010-11-10       Impact factor: 5.103

2.  A candidate dual vaccine against influenza and noroviruses.

Authors:  Ming Xia; Ming Tan; Chao Wei; Weiming Zhong; Leyi Wang; Monica McNeal; Xi Jiang
Journal:  Vaccine       Date:  2011-08-11       Impact factor: 3.641

3.  Structural Evolution of the Emerging 2014-2015 GII.17 Noroviruses.

Authors:  Bishal Kumar Singh; Anna Koromyslova; Lisa Hefele; Clara Gürth; Grant S Hansman
Journal:  J Virol       Date:  2015-12-23       Impact factor: 5.103

4.  Terminal modifications of norovirus P domain resulted in a new type of subviral particles, the small P particles.

Authors:  Ming Tan; Ping-An Fang; Ming Xia; Teepanis Chachiyo; Wen Jiang; Xi Jiang
Journal:  Virology       Date:  2010-12-23       Impact factor: 3.616

5.  Emergence of new pandemic GII.4 Sydney norovirus strain correlates with escape from herd immunity.

Authors:  Kari Debbink; Lisa C Lindesmith; Eric F Donaldson; Veronica Costantini; Martina Beltramello; Davide Corti; Jesica Swanstrom; Antonio Lanzavecchia; Jan Vinjé; Ralph S Baric
Journal:  J Infect Dis       Date:  2013-08-01       Impact factor: 5.226

6.  Affinities of recombinant norovirus P dimers for human blood group antigens.

Authors:  Ling Han; Pavel I Kitov; Elena N Kitova; Ming Tan; Leyi Wang; Ming Xia; Xi Jiang; John S Klassen
Journal:  Glycobiology       Date:  2012-10-30       Impact factor: 4.313

7.  Identification and characterization of antibody-binding epitopes on the norovirus GII.3 capsid.

Authors:  Jackie E Mahar; Nicole C Donker; Karin Bok; Gert H Talbo; Kim Y Green; Carl D Kirkwood
Journal:  J Virol       Date:  2013-11-27       Impact factor: 5.103

8.  The importance of intergenic recombination in norovirus GII.3 evolution.

Authors:  Jackie E Mahar; Karin Bok; Kim Y Green; Carl D Kirkwood
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

9.  Identifying carbohydrate ligands of a norovirus P particle using a catch and release electrospray ionization mass spectrometry assay.

Authors:  Ling Han; Elena N Kitova; Ming Tan; Xi Jiang; John S Klassen
Journal:  J Am Soc Mass Spectrom       Date:  2013-10-05       Impact factor: 3.109

10.  Conservation of carbohydrate binding interfaces: evidence of human HBGA selection in norovirus evolution.

Authors:  Ming Tan; Ming Xia; Yutao Chen; Weiming Bu; Rashmi S Hegde; Jarek Meller; Xuemei Li; Xi Jiang
Journal:  PLoS One       Date:  2009-04-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.